Transfer of Plasmid-Mediated CTX-M-9 from Salmonella enterica Serotype Virchow to Enterobacteriaceae in Human Flora-Associated Rats Treated with Cefixime
- 1 January 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (1) , 164-169
- https://doi.org/10.1128/aac.00310-09
Abstract
Food animals are a potential source of CTX-M resistance genes for humans. We evaluated the transfer of the bla(CTX-M-9) gene from an animal strain of Salmonella enterica serotype Virchow to Enterobacteriaceae of the human intestinal flora by using human flora-associated (HFA) rats with and without cefixime treatment. In the absence of antibiotic, no transconjugant enterobacteria were found in the feces of HFA rats. However, the transfer rate was high if Escherichia coli J5 recipient strains were coinoculated orally with Salmonella. S. enterica serotype Virchow persisted in the rat fecal flora both during and after treatment with therapeutic doses of cefixime. The drug did not increase the transfer rate, and E. coli J5 transconjugants were eliminated from the flora before the end of cefixime treatment. No cefixime was recovered in the rat feces. In the presence of recipient strains, the bla(CTX-M-9) resistance gene was transferred from a strain of animal origin to the human intestinal flora, although transconjugant colonization was transient. Antibiotic use enhanced the persistence of donor strains, increasing the resistance gene pool and the risk of its spread.Keywords
This publication has 53 references indexed in Scilit:
- Impact of Therapeutic Treatment with β-Lactam on Transfer of the bla CTX-M-9 Resistance Gene from Salmonella enterica Serovar Virchow to Escherichia coli in Gnotobiotic RatsApplied and Environmental Microbiology, 2009
- Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestineJournal of Antimicrobial Chemotherapy, 2008
- Dissemination of Clonally RelatedEscherichia coliStrains Expressing Extended-Spectrum β-Lactamase CTX-M-15Emerging Infectious Diseases, 2008
- Comparative Analysis of IncHI2 Plasmids Carrying bla CTX-M-2 or bla CTX-M-9 from Escherichia coli and Salmonella enterica Strains Isolated from Poultry and HumansAntimicrobial Agents and Chemotherapy, 2007
- Spread of Extended-Spectrum β-Lactamase CTX-M-Producing Escherichia coli Clinical Isolates in Community and Nosocomial Environments in PortugalAntimicrobial Agents and Chemotherapy, 2007
- Emergence and Dissemination of Enterobacteriaceae Isolates Producing CTX-M-1-Like Enzymes in Spain Are Associated with IncFII (CTX-M-15) and Broad-Host-Range (CTX-M-1, -3, and -32) PlasmidsAntimicrobial Agents and Chemotherapy, 2007
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Clonal Emergence of Extended-Spectrum β-Lactamase (CTX-M-2)-Producing Salmonella enterica Serovar Virchow Isolates with Reduced Susceptibilities to Ciprofloxacin among Poultry and Humans in Belgium and France (2000 to 2003)Journal of Clinical Microbiology, 2006
- Efficacité et tolérance de deux formulations orales d'Augmentin® 1 g/125 mg deux fois par jour versus 500 mg/125 mg trois fois par jour dans les exacerbations aiguës de bronchite chronique. Étude multicentrique, comparative, randomisée, en double aveugleMedecine Et Maladies Infectieuses, 2000
- Induction of β-Lactamase Production in the Anaerobic Microflora by CefoxitinClinical Infectious Diseases, 1995